FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016977489> ?p ?o ?g. }

• W2016977489 endingPage "v66" @default.
• W2016977489 startingPage "v59" @default.
• W2016977489 abstract "Vascular calcification is the most common type of extra-osseous calcification in end-stage renal disease (ESRD), manifesting as both medial and intimal calcification of large arteries. It is highly prevalent, often progressive and is associated with reduced arterial elasticity and increased mortality. Risk factors for calcification in ESRD include age, duration of dialysis, diabetes mellitus, most probably an elevated calcium-phosphorus product (Ca x P) level, the dose of calcium-containing phosphate binders and the induction of the systemic inflammatory response. Uraemic calcification was thought to be a largely physico-chemical process facilitated by elevated Ca x P (i.e. metastatic calcification). It is now well established, however, that vascular smooth muscle cells actively take up phosphate to form bioapatite. This process is associated with a phenotypic transformation of vascular smooth muscle cells during which they express osteoblast markers. In addition to phosphate, various other factors are likely to increase bioapatite formation, e.g. lipids and inflammatory cytokines. There have also been relatively new insights relating to the role of endogenous inhibitors of calcification [i.e. matrix Gla protein and fetuin-A (alpha(2)-Heremans-Schmid glycoprotein)], in particular the downregulation of fetuin-A in systemic inflammation. Decreased serum fetuin-A has been shown to be associated with a reduced capacity to inhibit calcium phosphate precipitation in vitro and is predictive of mortality in dialysis patients. These new insights into pathogenesis may lead to better prevention and treatment of calcification (e.g. with calcimimetics, anti-cytokines, etc.). However, the only preventive approach to have been established prospectively to date is the replacement of calcium-containing phosphate binders with sevelamer HCl, a non-calcaemic phosphate binder. Yet, it remains unclear whether sevelamer HCl reduces vascular calcification by preventing episodes of hypercalcaemia and/or by reducing low-density lipoprotein (LDL)-cholesterol levels." @default.
• W2016977489 created "2016-06-24" @default.
• W2016977489 creator A5001027249 @default.
• W2016977489 creator A5046643853 @default.
• W2016977489 date "2004-08-01" @default.
• W2016977489 modified "2023-10-13" @default.
• W2016977489 title "Vascular calcification in patients with end-stage renal disease" @default.
• W2016977489 cites W1849853209 @default.
• W2016977489 cites W1966120281 @default.
• W2016977489 cites W1968804919 @default.
• W2016977489 cites W1973302761 @default.
• W2016977489 cites W1973948354 @default.
• W2016977489 cites W1978160716 @default.
• W2016977489 cites W1984044427 @default.
• W2016977489 cites W2008678562 @default.
• W2016977489 cites W2009810030 @default.
• W2016977489 cites W2010414135 @default.
• W2016977489 cites W2013009411 @default.
• W2016977489 cites W2021905629 @default.
• W2016977489 cites W2025136911 @default.
• W2016977489 cites W2030777261 @default.
• W2016977489 cites W2033356850 @default.
• W2016977489 cites W2035844132 @default.
• W2016977489 cites W2042574128 @default.
• W2016977489 cites W2045310089 @default.
• W2016977489 cites W2045847718 @default.
• W2016977489 cites W2048846473 @default.
• W2016977489 cites W2056966408 @default.
• W2016977489 cites W2058579856 @default.
• W2016977489 cites W2065763027 @default.
• W2016977489 cites W2065979244 @default.
• W2016977489 cites W2085071880 @default.
• W2016977489 cites W2086615343 @default.
• W2016977489 cites W2088868188 @default.
• W2016977489 cites W2096951494 @default.
• W2016977489 cites W2101385628 @default.
• W2016977489 cites W2108634795 @default.
• W2016977489 cites W2114164409 @default.
• W2016977489 cites W2120166750 @default.
• W2016977489 cites W2121904900 @default.
• W2016977489 cites W2123780246 @default.
• W2016977489 cites W2124210131 @default.
• W2016977489 cites W2129352623 @default.
• W2016977489 cites W2129503078 @default.
• W2016977489 cites W2130149021 @default.
• W2016977489 cites W2144652526 @default.
• W2016977489 cites W2149252002 @default.
• W2016977489 cites W2149439703 @default.
• W2016977489 cites W2153785016 @default.
• W2016977489 cites W2154497747 @default.
• W2016977489 cites W2156467557 @default.
• W2016977489 cites W2159593975 @default.
• W2016977489 cites W2161706310 @default.
• W2016977489 cites W2164591127 @default.
• W2016977489 cites W2167455623 @default.
• W2016977489 cites W2170029838 @default.
• W2016977489 cites W2314023744 @default.
• W2016977489 cites W2314327457 @default.
• W2016977489 cites W2324841714 @default.
• W2016977489 cites W2414203093 @default.
• W2016977489 cites W3144430126 @default.
• W2016977489 cites W2117582110 @default.
• W2016977489 doi "https://doi.org/10.1093/ndt/gfh1058" @default.
• W2016977489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15284362" @default.
• W2016977489 hasPublicationYear "2004" @default.
• W2016977489 type Work @default.
• W2016977489 sameAs 2016977489 @default.
• W2016977489 citedByCount "171" @default.
• W2016977489 countsByYear W20169774892012 @default.
• W2016977489 countsByYear W20169774892013 @default.
• W2016977489 countsByYear W20169774892014 @default.
• W2016977489 countsByYear W20169774892015 @default.
• W2016977489 countsByYear W20169774892016 @default.
• W2016977489 countsByYear W20169774892017 @default.
• W2016977489 countsByYear W20169774892018 @default.
• W2016977489 countsByYear W20169774892019 @default.
• W2016977489 countsByYear W20169774892020 @default.
• W2016977489 countsByYear W20169774892021 @default.
• W2016977489 countsByYear W20169774892022 @default.
• W2016977489 countsByYear W20169774892023 @default.
• W2016977489 crossrefType "journal-article" @default.
• W2016977489 hasAuthorship W2016977489A5001027249 @default.
• W2016977489 hasAuthorship W2016977489A5046643853 @default.
• W2016977489 hasBestOaLocation W20169774891 @default.
• W2016977489 hasConcept C126322002 @default.
• W2016977489 hasConcept C134018914 @default.
• W2016977489 hasConcept C2777466421 @default.
• W2016977489 hasConcept C2778063415 @default.
• W2016977489 hasConcept C2778653478 @default.
• W2016977489 hasConcept C2779395532 @default.
• W2016977489 hasConcept C2779978075 @default.
• W2016977489 hasConcept C2780309369 @default.
• W2016977489 hasConcept C2780804394 @default.
• W2016977489 hasConcept C2780814755 @default.
• W2016977489 hasConcept C2780942790 @default.
• W2016977489 hasConcept C2992686903 @default.
• W2016977489 hasConcept C3019040382 @default.
• W2016977489 hasConcept C3951539 @default.

• next